{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:07:12Z","timestamp":1793678832613,"version":"4.5.1"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.1001\/jamacardio.2020.7478","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T07:07:08Z","timestamp":1613027228000},"page":"593","source":"Crossref","is-referenced-by-count":162,"title":["Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care"],"prefix":"10.1001","volume":"6","author":[{"given":"Merrill","family":"Thomas","sequence":"first","affiliation":[{"name":"Saint Luke\u2019s Mid America Heart Institute, University of Missouri\u2013Kansas City, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Jones","sequence":"additional","affiliation":[{"name":"Saint Luke\u2019s Mid America Heart Institute, University of Missouri\u2013Kansas City, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne V.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Saint Luke\u2019s Mid America Heart Institute, University of Missouri\u2013Kansas City, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[{"name":"Saint Luke\u2019s Mid America Heart Institute, University of Missouri\u2013Kansas City, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"15","key":"hrv200010r1","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease.","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"hrv200010r2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease.","volume":"359","author":"Weintraub","year":"2008","journal-title":"N Engl J Med"},{"issue":"15","key":"hrv200010r3","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/jama.2013.279208","article-title":"Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial.","volume":"310","author":"Abdallah","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"hrv200010r4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ahj.2005.05.026","article-title":"The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)\u2014evaluating the impact of myocardial infarction on patient outcomes.","volume":"151","author":"Spertus","year":"2006","journal-title":"Am Heart J"},{"issue":"4","key":"hrv200010r5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1161\/CIRCOUTCOMES.110.960468","article-title":"Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients\u2019 Health Status (TRIUMPH): design and rationale of a prospective multicenter registry.","volume":"4","author":"Arnold","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"20","key":"hrv200010r6","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.107.747568","article-title":"Evolving applications for patient-centered health status measures.","volume":"118","author":"Spertus","year":"2008","journal-title":"Circulation"},{"key":"hrv200010r7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ahj.2016.02.015","article-title":"Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study.","volume":"175","author":"Shafiq","year":"2016","journal-title":"Am Heart J"},{"issue":"16","key":"hrv200010r8","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archinternmed.2009.295","article-title":"The prevalence of weekly angina among patients with chronic stable angina in primary care practices: the Coronary Artery Disease in General Practice (CADENCE) study.","volume":"169","author":"Beltrame","year":"2009","journal-title":"Arch Intern Med"},{"issue":"6","key":"hrv200010r9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7406","article-title":"Comparison of patient-reported vs physician-estimated angina in patients undergoing elective and urgent percutaneous coronary intervention.","volume":"3","author":"Saxon","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"hrv200010r10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ehjqcco\/qcw016","article-title":"Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease.","volume":"2","author":"Qintar","year":"2016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"6","key":"hrv200010r11","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/01.CIR.64.6.1227","article-title":"Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.","volume":"64","author":"Goldman","year":"1981","journal-title":"Circulation"},{"issue":"2","key":"hrv200010r12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"hrv200010r13","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/0002-9149(94)90555-X","article-title":"Monitoring the quality of life in patients with coronary artery disease.","volume":"74","author":"Spertus","year":"1994","journal-title":"Am J Cardiol"},{"issue":"4","key":"hrv200010r14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1067\/mhj.2001.112781","article-title":"Testing the effectiveness of converting patients to long-acting antianginal medications: the Quality of Life in Angina Research Trial (QUART).","volume":"141","author":"Spertus","year":"2001","journal-title":"Am Heart J"},{"issue":"5","key":"hrv200010r16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.114.000967","article-title":"Development and validation of a short version of the Seattle Angina Questionnaire.","volume":"7","author":"Chan","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"hrv200010r17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ahj.2018.04.012","article-title":"Validation of the Seattle Angina Questionnaire in women with ischemic heart disease.","volume":"201","author":"Patel","year":"2018","journal-title":"Am Heart J"},{"issue":"5","key":"hrv200010r18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001767","article-title":"Standardized outcome measurement for patients with coronary artery disease: consensus from the International Consortium for Health Outcomes Measurement (ICHOM).","volume":"4","author":"McNamara","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"hrv200010r19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/01.CIR.0000020688.24874.90","article-title":"Health status predicts long-term outcome in outpatients with coronary disease.","volume":"106","author":"Spertus","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"hrv200010r20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1161\/CIRCOUTCOMES.113.000752","article-title":"Comparison of the Seattle Angina Questionnaire with daily angina diary in the TERISA clinical trial.","volume":"7","author":"Arnold","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"hrv200010r21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/CIRCOUTCOMES.108.829523","article-title":"Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.","volume":"2","author":"Arnold","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"hrv200010r22","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ahj.2004.12.010","article-title":"Monitoring clinical changes in patients with heart failure: a comparison of methods.","volume":"150","author":"Spertus","year":"2005","journal-title":"Am Heart J"},{"issue":"26","key":"hrv200010r23","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"An assessment of clinically useful measures of the consequences of treatment.","volume":"318","author":"Laupacis","year":"1988","journal-title":"N Engl J Med"},{"issue":"2","key":"hrv200010r24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCOUTCOMES.108.798009","article-title":"Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.","volume":"1","author":"Arnold","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"14","key":"hrv200010r25","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1161\/01.CIR.0000087600.83707.FD","article-title":"Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial.","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"hrv200010r26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hrv200010r27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jacc.2004.10.034","article-title":"Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non\u2013ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of Unstable Angina (RITA-3).","volume":"45","author":"Kim","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hrv200010r28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","article-title":"In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women\u2019s Ischemia Syndrome Evaluation (WISE).","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J"},{"issue":"6","key":"hrv200010r29","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/S0735-1097(01)01599-6","article-title":"Quality of life after balloon angioplasty or stenting for acute myocardial infarction. one-year results from the Stent-PAMI trial.","volume":"38","author":"Rinfret","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"10115","key":"hrv200010r30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"issue":"17","key":"hrv200010r31","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1161\/CIRCULATIONAHA.118.033801","article-title":"Fractional flow reserve and instantaneous wave-free ratio as predictors of the placebo-controlled response to percutaneous coronary intervention in stable single-vessel coronary artery disease.","volume":"138","author":"Al-Lamee","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"hrv200010r32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004111","article-title":"Precision medicine for cardiac resynchronization: predicting quality of life benefits for individual patients\u2014an analysis from 5 clinical trials.","volume":"10","author":"Nassif","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"5","key":"hrv200010r33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1161\/CIRCOUTCOMES.116.002781","article-title":"Predictors of physician under-recognition of angina in outpatients with stable coronary artery disease.","volume":"9","author":"Arnold","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"11","key":"hrv200010r34","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1001\/jamainternmed.2020.3181","article-title":"Potential association of the ISCHEMIA trial with the appropriate use criteria ratings for percutaneous coronary intervention in stable ischemic heart disease.","volume":"180","author":"Malik","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"17","key":"hrv200010r35","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.jacc.2017.02.001","article-title":"ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.","volume":"69","author":"Patel","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"hrv200010r36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial.","volume":"34","author":"Basch","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"hrv200010r37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment.","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"issue":"15","key":"hrv200010r38","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease.","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"hrv200010r39","first-page":"1","article-title":"Cardiovascular survey methods.","volume":"56","author":"Rose","year":"1968","journal-title":"Monogr Ser World Health Organ"},{"issue":"12","key":"hrv200010r40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003665","article-title":"Dyspnea among patients with chronic total occlusions undergoing percutaneous coronary intervention: prevalence and predictors of improvement.","volume":"10","author":"Qintar","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"hrv200010r41","first-page":"369","article-title":"Integrating baseline health status data collection into the process of care.","volume":"27","author":"Spertus","year":"2001","journal-title":"Jt Comm J Qual Improv"},{"key":"hrv200010r15","unstructured":"Centers for Medicare & Medicaid Services. Hospital-level patient-reported outcome-based performance measure for patients undergoing non-emergent percutaneous coronary intervention. Public comment summary report. Centers for Medicare & Medicaid Services; September 2, 2016. Accessed June 20, 2020. https:\/\/www.cms.gov\/Medicare\/Quality-Initiatives-Patient-Assessment-Instruments\/MMS\/Downloads\/Hospital-Level-PRO-Based-PM-for-Patients-Undergoing-non-Emergent-PCI_Public-Comment-Summary-Report.pdf"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2776242\/jamacardiology_thomas_2021_rv_200010_1620405974.64334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T17:41:12Z","timestamp":1620668472000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2776242"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2020.7478","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}